1. Introduction {#sec1}
===============

Congenital generalized lipodystrophy (CGL, Berardinelli-Seip syndrome) is a rare autosomal recessive disorder characterized by a lack of adipose tissue (AT). Affected individuals are prone to metabolic complications including insulin resistance, diabetes mellitus, hepatic steatosis and hypertriglyceridemia [@bib1], [@bib2].

Mutations in the *AGPAT2* gene, encoding 1-acylglycerol-3-phosphate O-acyltransferase 2, cause the most common form of CGL, designated CGL-1 [@bib3]. Patients with CGL-1 have total absence of metabolically active adipose tissue, which is present in most subcutaneous regions, intra-abdominal and intra-thoracic regions and bone marrow; mechanical adipose tissue, which is present in the palms, soles, scalp, peri-articular regions and orbits, is completely preserved [@bib4]. Similarly, mice lacking AGPAT2 (*Agpat2*^−/−^mice) have complete loss of both white and brown adipose tissue and manifest severe insulin resistance and hyperglycemia [@bib5], [@bib6]. The mechanisms underlying the loss of adipose tissue in *Agpat2*^−/−^ mice remain unknown.

AGPAT2 belongs to a family of enzymes catalyzing the *sn*-2 acylation of the glycerol-3-phosphate backbone. This reaction converts lysophosphatidic acid (LPA) to phosphatidic acid (PA) in the *de novo* glycerolipid synthesis pathway [@bib7]. In humans and mice, AGPAT2 is a ∼31 KDa protein with four predicted transmembrane domains [@bib8] and specificity for LPA and acyl-CoA substrates [@bib9], [@bib10]. Epitope tagged AGPAT2 localizes to the endoplasmic reticulum (ER) of CHO cells and primary mouse hepatocytes [@bib10].

Lipodystrophy can result from either insufficient generation of mature adipocytes, i.e. defective adipogenesis, or accelerated adipocytes loss, i.e., defective adipose maintenance. Previous work with cell lines [@bib11], [@bib12] and muscle-derived multipotent cells isolated from subjects harboring AGPAT2 mutations [@bib12] has suggested that AGPAT2 is required for adipogenic differentiation; however, the roles of AGPAT2 for *in vivo* adipose tissue dynamics is unknown.

Herein, we characterized morphological, ultrastructural, and molecular changes of AT from *Agpat2*^−/−^ mice and assessed adipogenic differentiation in *Agpat2*^−/−^ mouse embryonic fibroblasts (MEFs).

2. Materials and methods {#sec2}
========================

2.1. Mice {#sec2.1}
---------

*Agpat2*^−/−^ mice were generated as described previously [@bib5]. *Agpat2*^−/−^ and *Agpat2*^+/+^ mice were obtained by mating of *Agpat2*^*+/−*^ mice. Genotyping was performed by the PCR protocol as described [@bib5]. Adult mice were fed chow ad libitum. All mouse procedures were reviewed and approved by the Institutional Animal Care and Use Committee at Pontificia Universidad Católica de Chile and University of Texas Southwestern Medical Center (UTSW).

2.2. Mouse embryonic fibroblasts (MEFs) {#sec2.2}
---------------------------------------

*Agpat2*^*+/−*^ pregnant females (14.5 d.p.c.) were sacrificed by isoflurane overdose. The embryos were removed, washed with ice cold sterile PBS, and sacrificed by decapitation. Maternal tissues, placental membranes, and internal organs were removed, and carcasses were rinsed with PBS and manually minced. The resulting material was digested with 0.25% trypsin/1 mM EDTA for 3 h at 4 °C and centrifuged. Cells were resuspended in DMEM 4.5 g/L glucose, supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM [l]{.smallcaps}-glutamine, 0.1 mM nonessential amino acids, 100 μg/ml penicillin/streptomycin, and 0.1 mM 2-β-mercaptoethanol and seeded onto 150 mm plastic dishes. Because of *Agpat2*^*+/−*^ mice mating, the embyros are of all three genotypes: *Agpat2*^*+/+*^; *Agpat2*^*+/−*^ and *Agpat2*^*−/−*^. Genomic DNA was isolated from tail biopsies of each embryo and only those of *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ genotypes were further processed. Genotyping PCR conditions are similar as mentioned before [@bib5]. MEFs were cultured until 100% confluence and frozen in liquid nitrogen at passage 1. All the experiments were performed at passage 3.

2.3. MEFs adipogenic differentiation {#sec2.3}
------------------------------------

4 × 10^5^ MEFs/well were seeded on 12-well plates and cultured in DMEM 4.5 g/L glucose, supplemented with 10% heat-inactivated FBS, 2 mM [l]{.smallcaps}-glutamine, 0.1 mM nonessential amino acids, 100 μg/ml penicillin/streptomycin, and 0.1 mM 2-β-mercaptoethanol. Adipogenesis was induced 2 days after confluency with induction medium (standard medium plus 1 μM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 10 μg/ml insulin) for 3 days. After induction, MEFs were fed an adipogenic differentiation medium (standard medium plus 10 μg/ml insulin and 10 μM rosiglitazone) for 2 additional days and then cultured in adipogenic maintenance medium (standard medium supplemented with 10 μg/ml insulin).

2.4. Histology and immunofluorescence {#sec2.4}
-------------------------------------

E18.5 embryos and newborn mice were euthanized by CO~2~ anesthesia following cervical decapitation. Immediately, they were rinsed with 1X PBS and fixed overnight in 4% PFA/PBS and then transferred into 30--18% sucrose/PBS gradient. For histological studies in dorsal skin and interscapular BAT (iBAT) of P0-P6.5 mice, tissues were fixed in 4% PFA/PBS and then embedded in paraffin. Cryo and paraffin embedding, sectioning, H&E and Oil Red O staining were performed at UTSW Molecular Pathology Core. For Perilipin-1 and MAC-2 immunofluorescence in AT, sections were deparaffinized in xylene and rehydrated in a graded series of ethanol followed by dH~2~O. Antigen unmasking was carried out by heating slices in 10 mM sodium citrate buffer (pH 6.0) at 95--99 °C for 10 min. Tissue sections were blocked and then incubated overnight at 4 °C with primary antibodies. After the washing steps, fluorochrome-conjugated secondary antibodies were incubated for 1 h at room temperature. For immunofluorescence detection in cultured cells, MEFs were seeded on glass coverslips and adipogenic differentiation was induced as described above. At the indicated days, differentiated MEFs were fixed in 4% PFA, washed with PBS and permeabilizated/blocked in 0.3% Triton X-100; 3% BSA/PBS. Primary and secondary antibody incubation steps were performed as described above. Finally, all stained slides and coverslips were mounted with ProLong^®^ Gold Antifade Reagent with 4′,6′-diamidino-2-phenylindole (DAPI) (Molecular Probes). Images were captured with Leica SP5 Tandem Scanner Spectral 2-photon confocal microscope (Leica Microsystems, Inc., Buffalo Grove, IL) and processed with ImageJ (NIH, Bethesda, MD, US) and Bitplane Imaris software v. 7.3.1 (Andor Technology PLC, Belfast, N. Ireland). The following antibodies and dilutions were used: rabbit anti-Perilipin-1 (1:300, Cell Signalling), rabbit anti-Caveolin-1 (1:100, Cell Signalling), rabbit anti-PPARγ (1:100, Cell Signalling) and rat anti-MAC-2 (1:200, Cedarlane). Alexa Fluor^®^ 488 or 594 goat anti-rabbit IgG (H + L) and Alexa Fluor^®^ 488 goat anti-rat IgG (Molecular Probes) were diluted 1:300 in blocking buffer. F-actin was stained with rhodamine phalloidin (1:30 in PBS, Molecular Probes). For neutral lipid staining in MEFs, samples were incubated with 1 μg/ml BODIPY 493/503 (Molecular Probes).

2.5. TUNEL assay {#sec2.5}
----------------

Apoptotic cells were detected by the terminal deoxynucleotidyl-transferase-mediated deoxyuridine-triphosphate-biotin nick-end labeling (TUNEL) method using DeadEnd Fluorometric TUNEL System (Promega, Madison, WI) according the manufacturer\'s protocol. For TUNEL/Perilipin-1 double-labeled assay, paraffin sections of adipose tissue were first treated for TUNEL staining followed by immunofluorescent detection of Perilipin-1. Nuclei were counterstained with propidium iodide or DAPI as indicated. Stained samples were examined by confocal scanning laser microscopy.

2.6. Transmission electron microscopy {#sec2.6}
-------------------------------------

Dissected tissues from anterior subcutaneous regions and differentiated MEFs were fixed in 2% glutaraldehyde; 0.1 M cacodylate buffer and processed at the UTSW Electron Microscopy Core Facility. Sections were examined with a TEM Tecnai Spirit electron microscope and photographed with a Morada CCD camera.

2.7. Immunoblot analysis and antibodies {#sec2.7}
---------------------------------------

MEF protein extracts were prepared in RIPA buffer (50 mM Tris pH 8.0, 180 mM NaCl, 1% NP-40, 1% sodium deoxycholic acid, 0.1 mM EGTA and 0.1% sodium dodecyl sulfate (SDS)) supplemented with protease and phosphatase inhibitor cocktails (Roche) and 1 mM phenylmethylsulfonyl fluoride (PMSF). Proteins (50 μg) were denaturated in Laemmli\'s sample buffer (62.5 mM Tris, pH 6.8, 2% SDS, 25% glycerol, 0.01% bromophenol blue, and 5% β-mercaptoethanol), separated in a SDS-polyacrylamide gel and electrotransferred onto a nitrocellulose membrane. Membranes were blocked with 5% bovine serum albumin (BSA)/tris phosphate buffer 0.1% Tween 20 (TBS-T) and incubated overnight at 4 °C with primary antibodies diluted in 5% BSA/TBS-T solution. Rabbit antibodies against PPARγ, C/EBPα, C/EBPβ, C/EBPγ, β-actin, ATG12, Beclin, Akt (pan) and anti-rabbit IgG, HRP-linked antibodies were all purchased from Cell Signalling. Blots were visualized by chemiluminescence detection using Super Signal^®^ West Pico Reagents (Pierce).

2.8. Real-time reverse transcription PCR {#sec2.8}
----------------------------------------

Total RNA was extracted from iBAT, posterior subcutaneous AT and MEFs using RNA STAT-60 reagent (TEL-TEST). 2 μg of total RNA were reverse transcribed with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Real-time PCR was performed on ABI Prism^®^ 7900 HT thermalcycler (Applied Biosystems) using SYBR^®^ Green PCR Master Mix (Applied Biosystems) as reported [@bib5]. Individual mRNA levels were normalized to 36B4 and expressed as fold-change relative to non-differentiated *Agpat2*^+/+^ MEFs or wild type mice AT, with the ΔΔCt method. Primer sequences used for real time PCR are provided in [Supplementary Table 1](#appsec2){ref-type="sec"}.

2.9. Recombinant adenovirus {#sec2.9}
---------------------------

PPARγ2 encoding adenovirus was generated with ViraPower adenoviral expression system (Invitrogen). The PPARγ2 cDNA was amplified with Phusion high fidelity DNA polymerase (New England Biolabs) from a mouse liver cDNA library. PCR products were gel-purified and cloned into pENTR/D-TOPO vector (Invitrogen). The orientation and the sequence of the inserted cDNAs were confirmed by sequencing. Recombinant adenoviral vectors were generated by Clonase II mediated recombination between PPARγ2-pENTR/D-TOPO and pAd/CMV/V5-DEST vector (Invitrogen). Resulting recombinant plasmids were confirmed by sequencing. Infecting adenoviral particles were generated by transfecting 1 μg of PacI digested PPARγ2-pAD/CMV/V5-DEST in 293A cells using FuGENE 6 reagent (Roche Diagnostics). Adenoviral particles were purified in CsCl gradients and quantified by OD at 260 nm. 6 × 10^9^ adenoviral particles were used to transduce MEFs in 60 mm dishes.

2.10. Lipid extraction and phospholipid composition analysis {#sec2.10}
------------------------------------------------------------

Total triglycerides from differentiated MEFs were extracted and measured using Triglyceride Colorimetric Assay Kit (Cayman Chemicals) according to the manufacturer\'s instructions. To extract total glycerophospholipids, differentiated MEFs were collected and snap-frozen immediately in liquid nitrogen. Next, samples were homogenized with 2 ml of ice-cold Tris--HCl 20 mM containing protease inhibitors. Then, 0.8 the homogenized sample was vigorously mixed with CHCl~3~ and 0.1 N HCl:CH~3~OH methanol in a 0.8:1:1 ratio. Next, an equal amount of CHCl~3~ was added to the mix, manually shaken and centrifuged at 600 × g for 10 min at 4 °C. The lower phase was carefully removed and washed with a small volume of 1 M KCl. Extracted lipids were sent to Kansas Lipidomics Research Center (KLRC) for quantitation of phospholipid species. Automated electrospray ionization-tandem mass spectrometry approach was used, and data acquisition, analysis and identification were carried out as KLRC described previously [@bib13], [@bib14]. The data are presented as mol% of the total lipids analyzed.

2.11. Imaging analysis {#sec2.11}
----------------------

To quantify the number and size of adipocytes in histological sections of adipose tissue, adipocyte area was measured on hematoxylin and eosin stained slides using Adiposoft and ImageJ software as previously described [@bib15]. To determine the relative percentage of lipid-laden cells (cells containing LDs) after 6 days of differentiation, MEFs were grown on glass coverslips and differentiated. At day 6, cells were fixed and stained with BODIPY 493/503 to detect neutral lipids, rhodamine-phalloidin to detect cortical actin lining the inner surface of the plasma membrane in adipocytes [@bib16], [@bib17]), and DAPI to stain cell nuclei. Samples were imaged using a confocal microscope. For cell counting, five non-overlapping fields were analyzed and quantified using Image J software (each field contained approximately 150 cells). The relative percentage of lipid-laden cells was determined as the ratio of BODIPY/cortical F-actin labeled cells to the total cell number per field. For time-course experiments, lipid-laden cells were monitored under an inverted microscope with phase contrast objectives at different days of differentiation. Images from the sample fields were captured at each time and then analyzed with Image J software. Quantitative image analysis of fluorescence intensity was performed with Image J software as previously described [@bib18].

2.12. Statistical analysis {#sec2.12}
--------------------------

GraphPad Prism 5.00 (GraphPad, La Jolla, CA) was used for plotting and statistical analyses. Unpaired, two-sided Student\'s t-test was used to determine the statistical significance of the differences observed in two-group experiments. One-way ANOVA was used to compare three or more groups in some experiments. P-values of \<0.05 were considered significant. (\*), 0.01(\*\*), and 0.001(\*\*\*).

3. Results {#sec3}
==========

3.1. Newborn *Agpat2*^−/−^ mice are born with subcutaneous white and brown adipose tissues, which are lost during the first week of life {#sec3.1}
----------------------------------------------------------------------------------------------------------------------------------------

As we previously reported, AGPAT2 deficient adult mice are completely devoid of all white adipose tissue (WAT) and brown adipose tissue (BAT) depots [@bib5]. Surprisingly, and in contrast, fetuses and newborn *Agpat2*^−/−^ mice have preserved adipose tissue, as indicated by Oil Red O and Perilipin-1 staining of thoracic transversal section of E18.5 and newborn mice ([Figure 1](#fig1){ref-type="fig"}). Indeed, BAT was observed in the interscapular, subscapular, intercostal, and neck regions and had similar anatomic distribution and mass in both genotypes ([Figure 1](#fig1){ref-type="fig"}A). Analysis of the dorsal area showed a well-defined layer of subcutaneous Oil-red O stained ([Figure 1](#fig1){ref-type="fig"}B), Perilipin-1 expressing adipocytes ([Figure 1](#fig1){ref-type="fig"}C) located throughout the hypodermis as well as the dermis of all examined *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ mice. The thin layer of anterior-subcutaneous WAT (scWAT) was nearly intact in the *Agpat2*^*−/−*^ mice ([Figure 1](#fig1){ref-type="fig"}B--C). Interestingly, interscapular WAT, which normally covers the two lobes of interscapular BAT in adult mice [@bib19], [@bib20], was absent in E18.5 embryos and newborn (P0.5) *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ mice but it was detectable soon after birth exclusively in *Agpat2*^*+/+*^ (data not shown). This suggests that this particular WAT depot is always absent in the *Agpat2*^*−/−*^ mice, possibly because most of its development is postnatal and coincides with times when adipose degeneration is already active in these animals. Interestingly, depots of posterior-subcutaneous WAT, which are located mainly in the dorsal-lumbar and lower ventral regions of the adult mice [@bib20], [@bib21], [@bib22], [@bib23], were observed in transverse sections of the inguinal region of both *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ newborn mice ([Supplementary Figure 1A--B](#appsec2){ref-type="sec"}).

Histological analysis at postnatal times showed that subcutaneous adipocytes in wild type mice continuously increased their cell volume over the course of the first week ([Figure 2](#fig2){ref-type="fig"}A, upper panels). In *Agpat2*^*−/−*^ newborn mice at day P0.5, subcutaneous adipocytes were smaller and their size did not increase during the following days ([Figure 2](#fig2){ref-type="fig"}A, lower panels). Instead, the subcutaneous space of *Agpat2*^*−/−*^ mice was filled with multilocular cells that lacked adipocyte morphology ([Figure 2](#fig2){ref-type="fig"}A, lower panels).

In contrast to scWAT, abundant BAT was present in newborn *Agpat2*^*−/−*^ mice. Analysis of interscapular BAT (iBAT) showed normal multilocular brown adipocytes in the *Agpat2*^−/−^ mice at the time of birth (P0.5) ([Figure 2](#fig2){ref-type="fig"}B), indicating that brown adipocyte commitment and differentiation is normal in AGPAT2 deficient fetuses. Starting from P2.5, the iBAT of *Agpat2*^−/−^ mice showed aberrant lipid accumulation in brown adipocytes and progressive tissue deterioration, including a reduced number of multilocular adipocytes, abundant unilocular lipid laden cells, and inflammatory cell infiltration. At day P6.5, BAT was completely replaced by an amorphous basophilic material, cell debris, mononuclear cells and giant histiocytes surrounding large lipid drops, possibly reflecting coalesced material from dead adipocytes ([Figure 2](#fig2){ref-type="fig"}B).

Three-dimensional reconstruction of Perilipin-1 stained scWAT from newborn mice ([Figure 2](#fig2){ref-type="fig"}C) and adipocyte size quantification confirmed that most adipocytes were smaller in the *Agpat2*^*−/−*^ mice ([Figure 2](#fig2){ref-type="fig"}D). In addition, adipocyte number was drastically reduced at P2.5 in *Agpat2*^*−/−*^ mice ([Figure 2](#fig2){ref-type="fig"}E). Three-dimensional reconstruction of Perilipin-1 stained scWAT and iBAT sections from P4.5 mice supported that the AT in *Agpat2*^*−/−*^ mice had abnormal adipocytes and disorganized architecture ([Figure 2](#fig2){ref-type="fig"}F).

Gene expression analysis of adipocyte markers and adipogenic transcription factors was performed in AT at various times during the postnatal period. In the scWAT of wild type mice, mRNA levels of Leptin, Adiponectin, Perilipin-1, PPARγ and AGPAT2, progressively increased during the first week of life ([Figure 2](#fig2){ref-type="fig"}G) as has been previously observed [@bib22]. In contrast, the mRNA level of these genes remained either undetectable (Leptin) or very low (Adiponectin, Perilipin-1, PPARγ) in *Agpat2*^−/−^ scWAT ([Figure 2](#fig2){ref-type="fig"}G). In agreement with the morphological normality of BAT in newborn *Agpat2*^−/−^ mice ([Figure 2](#fig2){ref-type="fig"}B), transcript levels of Adiponectin, UCP1, CIDEA and PPARγ were similar between *Agpat2*^+/+^ and *Agpat2*^−/−^ mice at day P0.5 ([Figure 2](#fig2){ref-type="fig"}H). However, and matching the morphological deterioration of BAT in aging *Agpat2*^−/−^ mice, the expression levels of these genes progressively decreased after birth ([Figure 2](#fig2){ref-type="fig"}H). Interestingly, AT degeneration coincides with increased lipid accumulation in the livers of *Agpat2*^*−/−*^ mice ([Supplementary Figure 1C](#appsec2){ref-type="sec"}), suggesting that the development of the lipodystrophic phenotype triggers insulin resistance in these mice.

Transmission electron microscopy (TEM) analysis of adipocytes from anterior scWAT sections revealed a number of ultrastructural anomalies in white adipocytes of newborn *Agpat2*^−/−^ mice. Whereas *Agpat2*^*+/+*^ adipocytes were large, with one or two big sized LDs ([Figure 3](#fig3){ref-type="fig"}A), and had normally structured mitochondria ([Figure 3](#fig3){ref-type="fig"}C) and abundant caveolae in the plasma membrane ([Figure 3](#fig3){ref-type="fig"}C, red arrowheads); *Agpat2*^−/−^ adipocytes were smaller, had multiple LDs ([Figure 3](#fig3){ref-type="fig"}B), their mitochondria showed abnormal internal complexity ([Figure 3](#fig3){ref-type="fig"}D), and they had a markedly decreased number of caveolae ([Figure 3](#fig3){ref-type="fig"}D--E). Furthermore, *Agpat2*^−/−^ adipocytes showed abundant autophagic structures ([Figure 3](#fig3){ref-type="fig"}F--I, encircled in dashed red lines; [3J](#fig3){ref-type="fig"}). To evaluate whether the lack of caveolae in *Agpat2*^−/−^ adipocytes is due to reduced levels of Caveolin-1, a major structural protein of caveolae [@bib24], Caveolin-1 was inmunostained in the scWAT of these mice. Intriguingly, three-dimensional reconstruction of confocal images showed equivalent levels of Caveolin-1 in *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ adipocytes ([Figure 3](#fig3){ref-type="fig"}K--L). However, most *Agpat2*^−/−^ adipocytes showed abnormal distribution of Caveolin-1 ([Figure 3](#fig3){ref-type="fig"}K), possibly indicating altered trafficking or mislocalization of this protein in structures other than caveolae.

Combined, these observations suggest that both BAT and subcutaneous WAT adipocyte precursor commitment and differentiation take place normally in *Agpat2*^*−/−*^ fetuses and that postnatal lipodystrophic degeneration affects both lineages equally in these mice. Even though *Agpat2*^*−/−*^ mice are born with near normal BAT at the histological and molecular level the scWAT has distinct morphological abnormalities.

3.2. Lack of AGPAT2 triggers postnatal adipocyte death in mice {#sec3.2}
--------------------------------------------------------------

To evaluate the mechanism of postnatal AT degeneration in *Agpat2*^*−/−*^ mice, cell death was assessed by TUNEL staining and TEM. TUNEL-positive cells were undetectable in AT of wild type mice at days P0.5 and P4.5 ([Figure 4](#fig4){ref-type="fig"}A, left panels). In contrast, at day P0.5, TUNEL-positive cells were present in the scWAT of *Agpat2*^−/−^ mice and were very abundant in both scWAT and BAT at day P4.5 ([Figure 4](#fig4){ref-type="fig"}A, right panels). Three-dimensional reconstruction and surface rendering of confocal data from TUNEL/Perilipin-1 double-labeled scWAT ([Figure 4](#fig4){ref-type="fig"}B, upper panel) or BAT ([Figure 4](#fig4){ref-type="fig"}B, lower panel) sections revealed that most of the TUNEL-positive nuclei belonged to adipocytes in the *Agpat2*^*−/−*^ mice. Moreover, pyknotic nuclei were abundant in *Agpat2*^*−/−*^ BAT ([Figure 2](#fig2){ref-type="fig"}B, dashed area in high magnification panel).

TEM analysis revealed that the degeneration of the scWAT in *Agpat2*^*−/−*^ mice was also characterized by abundant apoptotic bodies of varying size ([Figure 4](#fig4){ref-type="fig"}C, red arrows), residual "free LDs" in the interstitial space ([Figure 4](#fig4){ref-type="fig"}C, yellow arrows) and neighboring phagocyte ([Figure 4](#fig4){ref-type="fig"}C, yellow arrowhead) surrounding the free lipid material extruded from dead adipocytes. Interestingly, "free LDs" have been previously described in models of obesity-associated adipocyte death, which is characterized by morphological features of necrosis, apoptosis, and pyroptosis [@bib25], [@bib26]. The examination of degenerating BAT also showed large areas of terminal cell disintegration with fragments of intracellular components, including abundant "free lipid" material ([Figure 4](#fig4){ref-type="fig"}C, areas outlined by red dashed lines) suggesting secondary necrosis [@bib27].

Abundant non-adipocyte cells were detected in the AT of *Agpat2*^−/−^ mice ([Figure 2](#fig2){ref-type="fig"}, [Figure 4](#fig4){ref-type="fig"}C). We speculated that they corresponded to inflammatory cells infiltrating the degenerating AT of *Agpat2*^−/−^ mice. To determine the identity of these cells, the macrophage cell-surface marker MAC-2 was assessed by immunofluorescence. At day P0.5, MAC-2 expressing cells were undetectable in the AT of both genotypes (data not shown); however, abundant MAC-2 positive macrophages were exclusively present in AT from *Agpat2*^−/−^ mice at day P4.5, remaining undetectable in the wild type mice at that time ([Figure 4](#fig4){ref-type="fig"}D). Consistent with this observation, mRNA levels for NFκB, Caspase-1, TNFα and IL-6 were increasingly abundant in the iBAT of *Agpat2*^−/−^ mice ([Figure 4](#fig4){ref-type="fig"}E).

These observations indicate that massive adipocyte death precludes the postnatal expansion and maintenance of WAT and BAT in *Agpat2*^*−/−*^ newborn mice and suggest that inflammatory infiltration plays a role in the lipodystrophic phenotype of these mice.

3.3. AGPAT2 deficient MEFs have impaired adipocyte differentiation *in vitro* {#sec3.3}
-----------------------------------------------------------------------------

To further analyze the importance of AGPAT2 for adipocyte differentiation, we evaluated the capacity of post-confluent mouse embryonic fibroblasts (MEFs) to differentiate into adipocyte-like cells *in vitro*.

After 6 days of adipogenic differentiation, nearly 50% of *Agpat2*^*+/+*^ MEFs accumulated neutral lipids as determined by BODIPY staining and cellularity analysis ([Figure 5](#fig5){ref-type="fig"}A--B). By contrast, only 28% of *Agpat2*^−/−^ MEFs differentiated to adipocyte-like cells ([Figure 5](#fig5){ref-type="fig"}A--B) and the total concentration of triglycerides was significantly lower in these cells ([Figure 5](#fig5){ref-type="fig"}C). The mRNA levels of key transcriptional regulators, enzymes, lipid transporters, lipid droplet (LD) associated proteins, and adipokines were also lower in adipogenically differentiated *Agpat2*^−/−^ MEFs ([Figure 5](#fig5){ref-type="fig"}D).

Perilipin-1 and Caveolin-1, both highly enriched proteins in mature adipocytes, were immunostained in MEFs after 6 days of differentiation to determine the phenotype of the lipid-laden cells. Abundant Perilipin-1 ([Figure 5](#fig5){ref-type="fig"}E) and Caveolin-1 ([Figure 5](#fig5){ref-type="fig"}F) were coating LDs and decorating the plasma membrane, respectively, in differentiated lipid-laden *Agpat2*^*+/+*^ MEFs. Interestingly, although lipid-laden cells were smaller in cultured *Agpat2*^*−/−*^ MEFs, Perilipin-1 properly coated LDs ([Figure 5](#fig5){ref-type="fig"}E). By contrast, Caveolin-1 was irregularly distributed, with a higher proportion localized in intracellular structures, possibly the Golgi complex ([Figure 5](#fig5){ref-type="fig"}F, white arrowheads). This abnormal distribution of Caveolin-1 was also present in subcutaneous adipocytes of *Agpat2*^*−/−*^ mice ([Figure 3](#fig3){ref-type="fig"}K).

TEM analysis of differentiated MEFs revealed ultrastructural differences between genotypes ([Figure 6](#fig6){ref-type="fig"}). Along with their characteristic large LDs, differentiated *Agpat2*^*+/+*^ MEFs showed abundant well-structured mitochondria ([Figure 6](#fig6){ref-type="fig"}A). In contrast, differentiated lipid-laden *Agpat2*^*−/−*^ MEFs had fewer mitochondria and the internal structure of these organelles was altered ([Figure 6](#fig6){ref-type="fig"}A--B). Similar to subcutaneous adipocytes of *Agpat2*^*−/−*^ mice ([Figure 3](#fig3){ref-type="fig"}F--I), AGPAT2 deficient MEFs had significant accumulation of autophagic structures ([Figure 6](#fig6){ref-type="fig"}A, C, yellow arrowheads; [6D](#fig6){ref-type="fig"}). Also as observed in mice adipocytes ([Figure 3](#fig3){ref-type="fig"}C--D), caveolae were abundant in the plasma membrane of differentiated *Agpat2*^*+/+*^ MEFs but were virtually absent in *Agpat2*^*−/−*^ MEFs ([Figure 6](#fig6){ref-type="fig"}E--F). To further characterize autophagy in differentiating *Agpat2*^*−/−*^ MEFs, autophagy-related (ATG) proteins were assessed by immunoblotting. ATG12-ATG5 conjugate is essential for autophagosome formation [@bib28], [@bib29] and has been shown to increase during the adipogenic differentiation in MEFs [@bib30]. Here, we observed that ATG12-ATG5 conjugates were progressively increased as differentiation progressed in MEFs of both genotypes, but were significantly higher in *Agpat2*^*−/−*^ MEFs at all the time points ([Supplementary Figure 2A](#appsec2){ref-type="sec"}). In contrast, levels of Beclin, which is an important regulator of vesicle nucleation during the initial steps of autophagy [@bib28], were similar between *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ MEFs during adipogenic differentiation ([Supplementary Figure 2B](#appsec2){ref-type="sec"}).

Taken together, our results support the idea that *Agpat2*^*−/−*^ MEFs are able to initiate the process of adipogenic differentiation; however, they undergo a wide variety of cellular abnormalities that finally block the terminal phase of adipogenesis.

3.4. PPARγ overexpression partially rescues adipogenesis in *Agpat2*^−/−^ MEFs {#sec3.4}
------------------------------------------------------------------------------

The nuclear receptor PPARγ, as well as the C/EBP family of transcription factors, are critical regulators of adipogenesis [@bib31], [@bib32]. Therefore, we assessed the expression levels of C/EBPs and PPARγ during the adipogenic differentiation of MEFs. As expected, adipogenic induction resulted in early expression of C/EBPβ and C/EBPδ, followed by upregulation of C/EBPα and PPARγ mRNA and protein levels in *Agpat2*^*+/+*^ MEFs ([Figure 7](#fig7){ref-type="fig"}A--B). C/EBPβ, -δ, -α, and PPARγ were also increased after adipogenic induction of *Agpat2*^*−/−*^ MEFs, but the expression level of these markers was significantly lower at all the time points ([Figure 7](#fig7){ref-type="fig"}A--B). In spite of these differences, differentiated lipid-laden *Agpat2*^−/−^ MEFs have similar intensity of PPARγ immunofluorescence signal than wild type differentiated lipid-laden MEFs ([Figure 7](#fig7){ref-type="fig"}C).

To test if PPARγ overexpression could rescue the capacity of *Agpat2*^*−/−*^ MEFs to undergo full adipogenesis *in vitro*, post-confluent MEFs were infected with a PPARγ2 encoding adenovirus 24 h before adipogenic induction ([Figure 7](#fig7){ref-type="fig"}D). As previously reported [@bib33], [@bib34], [@bib35], [@bib36], we observed that overexpression of PPARγ2 enhanced the adipogenic potential of *Agpat2*^*+/+*^ MEFs in comparison with *Agpat2*^*+/+*^ MEFs uninfected or infected with a LacZ encoding adenovirus (data not shown). In *Agpat2*^*−/−*^ MEFs, PPARγ2 overexpression significantly increased the proportion of adipocyte-like cells after 6 days of differentiation ([Figure 7](#fig7){ref-type="fig"}E), as well as the total TG concentration ([Figure 7](#fig7){ref-type="fig"}F) and mRNA levels of adipocyte markers ([Figure 7](#fig7){ref-type="fig"}G) in comparison with *Agpat2*^*−/−*^ MEFs infected with a LacZ encoding adenovirus. Overexpression of PPARγ2 was unable to rescue the abnormal cellular morphology of differentiated *Agpat2*^*−/−*^ MEFs ([Figure 7](#fig7){ref-type="fig"}H). We noted that the proportion of lipid-laden *Agpat2*^*−/−*^ cells progressively declined during the course of the differentiation, in contrast with wild type cells that remained constant ([Supplementary Figure 2B](#appsec2){ref-type="sec"}). This anomaly was not corrected by PPARγ2 overexpression ([Supplementary Figure 2B](#appsec2){ref-type="sec"}), suggesting that PPARγ defects are not the main driving force for abnormal adipogenesis in AGPAT2 deficient adipocytes. To evaluate whether this decreasing number of *Agpat2*^*−/−*^ lipid-laden cells was the result of increased cell death, TUNEL analysis was performed in adipogenically induced MEFs cultures. Similar to our findings in postnatal adipose tissue of *Agpat2*^*−/−*^ mice ([Figure 4](#fig4){ref-type="fig"}A), a higher number of differentiated *Agpat2*^*−/−*^ MEFs was TUNEL-positive, in comparison with wild type MEFs ([Supplementary Figure 2C](#appsec2){ref-type="sec"}, left panels) and PPARγ2 overexpression was unable revert the cell death of *Agpat2*^*−/−*^ MEFs ([Supplementary Figure 2C](#appsec2){ref-type="sec"}, right panels).

3.5. Accumulation of phosphatidic acid and altered phospholipid composition in differentiated *Agpat2*^*−/−*^ MEFs {#sec3.5}
------------------------------------------------------------------------------------------------------------------

An altered phospholipid composition may perturb membrane remodeling, intracellular signaling, autophagy, and LD expandibility during adipogenesis [@bib37], [@bib38] and thus may be a determinant of death in AGPAT2 deficient adipocytes. Supporting this idea, it was previously reported that Caveolin-1 deficient adipocytes have abnormal phospholipid composition which is a determinant of small-sized LDs [@bib39]. Moreover, epidimal WAT and BAT depots from adipose-specific Seipin knockout mice have accumulation of several lipid species, including phospholipids, which is accompanied with cell stress and cell death of AT [@bib40].

Since the conversion of LPA to PA by AGPATs is an intermediary step involved in glycerophospholipid biosynthesis pathway ([Figure 8](#fig8){ref-type="fig"}A) and AGPAT2 expression is strongly elevated during adipocyte differentiation [@bib11], we aimed to determine whether the absence of AGPAT2 generates unbalanced levels of LPA, PA and potentially other phospholipids during adipogenesis. Therefore, we quantified the abundance of total LPA, PA and major phospholipids in differentiated *Agpat2*^*−/−*^ MEFs. Mass spectrometry analysis revealed no significant differences in the LPA content between differentiated *Agpat2*^*−/−*^ and *Agpat2*^*+/+*^ MEFs. In contrast, levels of PA were ∼3-fold higher in differentiated *Agpat2*^−/−^ MEFs in comparison with wild type MEFs ([Figure 8](#fig8){ref-type="fig"}B), indicating that alternative pathway(s) exist for the synthesis of PA in the absence of AGPAT2. Although the specific molecular identity of the fatty acid moieties composing PA were not revealed by our mass spectrometry analysis, differentiated *Agpat2*^*−/−*^ MEFs had significantly elevated levels of 32:1, 32:0 and 34:1 PA species ([Figure 8](#fig8){ref-type="fig"}C). In addition, increased levels of phosphatidylcholine (PC) and decreased levels of phosphatidylserine (PS), phosphatidylinositol (PI) and phosphatidylglycerol (PG), were detected in differentiated *Agpat2*^*−/−*^ MEFs ([Figure 8](#fig8){ref-type="fig"}D). Therefore, complex changes in the phospholipid composition may disrupt not only the production of lipid mediators but also the membrane properties, lipid droplet expansion, and adipocyte survival of AGPAT2 deficient adipocytes.

4. Discussion {#sec4}
=============

Here we report that, in contrast to adult *Agpat2*^−/−^ mice, late fetuses and newborn *Agpat2*^−/−^ mice have near normal scWAT and iBAT with similar distribution and mass as in the wild type littermates and that lipodystrophy results from massive adipocyte death during the first week of life. At the ultrastructural level, white adipocytes in newborn *Agpat2*^−/−^ were smaller and had a marked reduction of plasma membrane caveolae, abnormally structured mitochondria and irregular LDs. In addition, enhanced accumulation of autophagic structures observed in *Agpat2*^*−/−*^ adipocytes suggests that alternative pathways might be responsible for the widespread adipocyte death observed in the days following birth.

Our *in vitro* studies underscore the importance of AGPAT2 during adipogenesis. It is noteworthy that *Agpat2*^*−/−*^ MEF cells were able to differentiate into adipocyte-like cells but in a lower proportion than *Agpat2*^*+/+*^ MEFs. This difference was evident at early stages of adipogenesis and manifested by severely reduced abundance of C/EBPs and PPARγ at both the mRNA and protein levels. Nonetheless, immunofluorescence analysis suggested that the levels of nuclear PPARγ was equivalent between differentiated lipid-laden *Agpat2*^−/−^ and wild type MEFs. Treatment of *Agpat2*^*−/−*^ MEFs with the PPARγ agonist, rosiglitazone, during adipogenic induction did not improve adipogenesis (data not shown); however, overexpression of PPARγ2 increased the proportion of *Agpat2*^*−/−*^ MEFs with adipocyte-like phenotype after adipogenic induction, although it did not prevent the increased death of differentiated *Agpat2*^*−/−*^ MEFs. Importantly, *Agpat2*^−/−^ lipid-laden MEFs also exhibit other additional hallmarks of adipogenic differentiation, including neutral lipid accumulation, presence of Perilipin-1 coated LDs and the expression of downstream adipogenic marker proteins such aP2/FABP4 and ATGL (data not shown). Combined, these results suggest that adipogenic actions of AGPAT2 may operate upstream of PPARγ and that PPARγ deficiency is not a major determinant of the impaired adipogenesis of *Agpat2*^*−/−*^ MEFs.

In spite of these findings, we observed several ultrastructural abnormalities in differentiated *Agpat2*^*−/−*^ MEFs, suggesting that these cells lack the ability to sustain the differentiation process to reach a fully mature adipocyte phenotype and eventually they die.

Interestingly, the small cellular size, the irregular localization of Caveolin-1 and the remarkable absence of caveolae in differentiated *Agpat2*^*−/−*^ MEFs suggest that the lipodystrophy associated with mutations in *AGPAT2*, *CAV1*, or *PTRF* genes [@bib41], [@bib42], [@bib43], [@bib44] may be mechanistically connected. Indeed, recent studies have shown that: 1) caveolae protect adipocytes against lipotoxicity-induced autolysis [@bib45]; 2) changes in Caveolin-1 distribution are related with the disappearance of caveolae in the plasma membrane [@bib46]; 3) autophagosome formation is constitutively activated in Caveolin-1 deficient adipocytes and in differentiated *Cav1*^−/−^ MEFs [@bib47]; and 4) *Cav1*^−/−^ adipocytes have increased levels of reactive species oxygen (ROS) and mitochondrial dysfunction in association with widespread adipocyte death [@bib48], [@bib49].

Notably, excessive accumulation of autophagic structures was also present in differentiated *Agpat2*^*−/−*^ MEFs, in association with increased ATG12/ATG5 complex but not Beclin levels. It is possible that the extensive accumulation of autophagic structures observed in *Agpat2*^*−/−*^ lipid-laden cells, as well as in *Agpat2*^−/−^ adipocytes *in vivo*, result from an altered autophagic flux or failed elimination of autophagic debris in these cells. It is also possible that the intracellular dysregulation of lipid species in differentiated *Agpat2*^*−/−*^ MEFs plays a role on this phenomenon. Therefore, detailed studies on autophagy dynamics will be needed to determine the actual status of autophagic processes in *Agpat2*^*−/−*^ adipocytes and its role in the lipodystrophy of *Agpat2*^*−/−*^ mice [@bib50].

We found an altered phospholipid composition in AGPAT2 deficient MEFs. At this point, we do not know whether the altered phospholipid levels are a consequence of abnormal lipid metabolism during adipogenesis of AGPAT2 deficient MEFs. Similarly, our studies do not allow us to conclude a causal role of phospholipid composition abnormalities on the adipogenic inability of *Agpat2*^−/−^ MEFs. Interestingly, increased levels of PA have been reported in other cellular models of adipogenic impairment, including OP9 and 3T3-L1 cells in which AGPAT2 [@bib11] and Seipin [@bib51] were knocked down, respectively. Indeed, mutations in the *Bscl2/Seipin* gene also cause CGL in humans [@bib52] and mice [@bib40], [@bib53], [@bib54], and *in vitro* studies with Seipin deficient cells have shown impaired adipogenesis [@bib53], [@bib55], altered lipid metabolism [@bib56], high levels of PA and supersized LD [@bib57], [@bib58], [@bib59]. Additionally, epidimal WAT and BAT depots from adipose-specific Seipin knockout mice have increased levels of total PA, ER-stress, inflammation and cell death [@bib40].

Interestingly, a recent study demonstrated that Seipin, AGPAT2, and Lipin-1 physically interact with each other forming a complex in the ER during adipogenesis [@bib60]. This interaction may regulate an efficient flux of PA to specific pathways during adipogenic differentiation and also may be important for adipocyte growth. Therefore, a tentative hypothesis is that the disruption of Seipin-AGPAT2-Lipin-1 complex by the absence of one of these proteins may dysregulate other intracellular processes in which PA is implicated, including signaling, membrane trafficking and remodeling and autophagy. In support of this hypothesis, it was recently reported that increased PA levels due to Lipin-1 deficiency have deleterious effects on mitochondrial function and also impairs the autophagy flux in muscle, leading to accumulation of autophagy-related structures [@bib61].

Although the mechanisms responsible for the elevated PA levels in AGPAT2 deficient cells remain unknown, alternative metabolic pathways must be activated to allow the synthesis of PA in these cells. In addition to the AGPAT-dependent synthesis, PA can be generated by hydrolysis of phosphatidylcholine or cardiolipin by phospholipase D superfamily members [@bib62], [@bib63], [@bib64]. PA can also be generated by phosphorylation of diacylglycerol (DAG) through the action of DAG kinases (DAGK) [@bib65] or by the addition of a fatty acid side chain to LPA through the action of other-non AGPAT LPA acyl transferases [@bib66], [@bib67]. A recent study did show the upregulation of Dagk and Pld in the livers of *Agpat2*^*−/−*^ mice [@bib68]. Further studies will be required to biochemically dissect these pathways and to elucidate the mechanism of abnormal phospholipid composition in adipogenically differentiated *Agpat2*^*−/−*^ MEFs.

A limitation of our study is that we could not study the *in vivo* lipid composition of *Agpat2*^*−/−*^ adipocytes. This was due to our technical inability to dissect the very minute mass of scWAT in embryos and newborn mice. Ongoing strategies are aimed to generate mouse models to purify specific cell populations in *Agpat2*^*−/−*^ mice. These will provide new tools to assess the role of specific lipid species in the ultrastructural anomalies dependent on AGPAT2 deficiency in adipocytes and for dissecting the specific mechanisms by which adipocyte cell death causes lipodystrophy in *Agpat2*^*−/−*^ mice.

In summary, we show that *Agpat2*^*−/−*^ mice are born with AT, which undergoes a rapid degenerative process that leads to the total destruction of AT during the first week after birth. At the ultrastructural level, *Agpat2*^*−/−*^ adipose tissue has decreased caveolae, abnormally conformed mitochondria and LDs amid abundant autophagic structures. Adipocyte-like cells from differentiated *Agpat2*^*−/−*^ MEFs recapitulate the abnormal phenotype observed in scWAT of *Agpat2*^*−/−*^ newborn mice and have an abnormal phospholipid composition.

Based on our *in vivo* and *in vitro* findings, we propose AGPAT2 deficient adipocytes have an impaired capacity to adapt to the massive lipid availability associated with postnatal feeding, leading to cellular stress, death and inflammatory destruction of adipose tissue.
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The following are the Supplementary data related to this article:Supplementary Figure 1**(A)** Oil red O/hematoxylin stained transversal sections at the inguinal level of newborn *Agpat2*^−/−^ mice. Bilateral subcutaneous inguinal WAT depots (left and middle images) are located between the skin and muscle fascia just anterior to the lower segment of the hind limbs. Higher magnification of the inguinal WAT depots stained with Oil red O (right image). **(B)** Perilipin-1 immunofluorescence staining (green) of inguinal WAT. F-actin was detected with phalloidin/rhodamine (red), indicating skeletal muscle. Nuclei were stained with DAPI (blue). **(C)** Development of hepatic steatosis matches adipose tissue destruction in *Agpat2*^*−/−*^ mice. Histological analysis (hematoxylin-eosin staining) shows growing lipids build up in the liver of *Agpat2*^*−/−*^ mice starting at P2.5. No differences between female and male *Agpat2*^*−/−*^ mice were detected.Supplementary Figure 2**(A)** Immunoblot analysis of whole-cell protein extracts from *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ MEFs at different days of differentiation. 50 μg of proteins were loaded, total Akt was used as loading control. **(B)** At the indicated times, the number of lipid-laden cells were counted as previously described. Graph shows the percentage of lipid-laden cells. **(C)** TUNEL assay in 10 days differentiated MEFs.
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![**Late fetuses and newborn *Agpat2***^***−/−***^**mice have normal adipose tissue mass, anatomical distribution and Perilipin-1 expression**. **(A)** Oil red O/hematoxylin stained transversal thoracic sections revealed normal distribution of adipose tissue in E18.5 fetuses and newborn *Agpat2*^+/+^ and *Agpat2*^−/−^ mice. **(B)** Higher magnification of the dorsal areas stained with Oil red O showed a thin layer of lipid-laden cells in the hypodermis corresponding to developing subcutaneous white adipose tissue (scWAT) in animals of both genotypes. scWAT is separated from the interscapular brown adipose tissue (iBAT) by the panniculus carnosus muscle (outlined by dashed line) **(C)** Perilipin-1 immunofluorescence staining (green) revealed that lipid-laden cells correspond to adipocytes expressing Perilipin-1. F-actin was detected with Phalloidin/rhodamine (red), indicating skeletal muscle. Nuclei were stained with DAPI (blue). Images are representative of 6 embryos or fetuses per genotype and age.](gr1){#fig1}

![**Postnatal adipose tissue development and growth are impaired in *Agpat2***^***−/−***^**mice**. **(A--B)** Paraffin-embedded sections of anterior scWAT and iBAT from *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ mice were obtained at different days of postnatal life and stained with Hematoxylin and Eosin. Slides were photographed at 40× magnification. Images are representative of N \> 6 per genotype and age **(C, F)** Three-dimension digital reconstruction of Perilipin-1 stained (green) adipose tissue depots from *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ mice at P0.5 (C) and P4.5 (F), DAPI was used to stain nuclei (blue). **(D)** Histogram shows adipocyte size distribution in scWAT of *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ newborn mice (P0.5). **(E)** Quantitative comparison of total number of adipocyte per field in scWAT of newborn and P4.5 *Agpat2*^*−/−*^ mice. Adipocyte number and size were analyzed using Adiposoft software. At least 1000 adipocytes and 5--6 different areas per mouse (N = 4) were analyzed. **(G--H)** Adipose tissue mRNA markers were assessed by qPCR in scWAT and iBAT depots at different pre and postnatal time points. Graphs represent the relative abundance of each transcript normalized to 36B4 mRNA. The bars show the mean ± standard deviation (SD) of N = 6. \*\*\*p \< 0.001 compared to *Agpat2*^+/+^ mice at E18.5.](gr2){#fig2}

![**Transmission electron microscopy reveals ultrastructural abnormalities in scWAT from newborn *Agpat2***^***−/−***^**mice**. **(A--D)** Representatives images of scWAT of *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ mice. Caveolae are depicted by red arrowhead. **(E)** Quantification of caveolae normalized against membrane length. **(F--I)** scWAT of *Agpat2*^*−/−*^ mice show small adipocytes with numerous lipid droplets (LD), abnormal mitochondria (m), autophagic structures (enclosed by dashed red lines for clarity), and absence of plasma membrane caveolae. **(J)** Representative quantification of autophagic structures per adipocyte on section. For image comparative analysis and quantification, 20 adipocytes per sample were analyzed with a total of N = 3 samples per experimental group. **(K)** Representative confocal co-immunofluorescence of caveolin-1 (red) and CD31 (magenta) on scWAT of newborn mice. Asterisks indicate *Agpat2*^*−/−*^ adipocytes with plasma membrane-associated Caveolin-1. **(L)** Quantitation of caveolin-1 immunofluorescence signal in adipocytes.](gr3){#fig3}

![**The loss of adipose tissue in *Agpat2***^***−/−***^**mice is associated with massive cell death and adipose inflammation**. **(A)** Paraffin-embedded sections of scWAT and iBAT from *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ littermates were assessed by TUNEL staining. **(B)** 3D slide reconstruction and surface rendering of confocal data from TUNEL/Perilipin-1 double-labeled scWAT and iBAT from P2.5 mice. Volume-rendering in yellow color highlights TUNEL and DAPI co-localization. **(C)** TEM of degenerating adipocytes in scWAT and iBAT from *Agpat2*^*−/−*^ mice at P4.5. scWAT: red arrows indicate apoptotic bodies, yellow arrows indicate free lipid material (free "LDs"), red arrowhead indicates a phagocytic cell, blood vessel is outlined by a red dashed line. iBAT: red dashed areas show trace of extensive cell disintegration and leakage of intracellular components including lipid material. **(D)** Paraffin-embedded sections of scWAT and iBAT from *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ littermates were stained with anti-MAC-2 and detected by immunofluorescence. **(E)** The mRNA level of genes involved in inflammatory response were assessed by qPCR at different postnatal time points in iBAT of Agpat2^+/+^ and Agpat2^−/−^ mice. Graphs show the relative abundance of each transcript normalized to 36B4 mRNA. The bars show the means ± SD of N = 8. \*\*\* denote significant difference (p \< 0.001) compared to *Agpat2*^+/+^ mice at E18.5.](gr4){#fig4}

![**Adipogenic differentiation of *Agpat2***^**−/−**^**MEFs results in significantly fewer neutral lipid-laden cells after 6 days of differentiation**. **(A)** Representative images (N \> 10) from 6 days differentiated MEFs stained with the neutral lipid dye BODIPY and DAPI. **(B)** Graph shows the grade of adipogenic differentiation expressed as percentage of BODIPY stained cells. **(C)** Graph shows total cellular triglycerides quantified by an enzymatic-colorimetric method. **(D)** mRNA levels of adipogenic transcription factors and adipocyte related markers were quantified by qPCR. Gene expression was normalized to 36B4 mRNA levels and presented as fold-change relative to non-differentiated *Agpat2*^*+/+*^ MEFs. Data correspond to the means ± SD of six independent experiments (N \> 10). \*\*\*p \< 0.001 and \*\*p \< 0.01 denote statistically significant difference compared to differentiated *Agpat2*^*+/+*^ MEFs after 6 days of differentiation. **(E)** Three dimensional digital reconstruction of fluorescence stacks of differentiated *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ MEFs stained with BODIPY and anti-Perilipin-1 antibody. **(F)** Representative confocal images of Caveolin-1 (red) and lipid droplets (green) in MEFs after 6 days of adipogenic differentiation. Caveolin-1 preferentially marks the plasma membrane but also intracellular structures, possibly the Golgi complex (white arrowheads).](gr5){#fig5}

![**AGPAT2 deficiency is associated with ultrastructural abnormalities in differentiated MEFs**. Transmission electron microscopy of differentiated *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ MEFs at day 6 post adipogenic induction. **(A)** Comparative images show lipid-laden cells from differentiated *Agpat2*^*−/−*^ MEFs (right panel) have aberrant mitochondria (m) and numerous autophagic structures (yellow arrowheads) in comparison with differentiated *Agpat2*^*+/+*^ MEFs (left panel). **(B)** Representative imaging of mitochondria from differentiated *Agpat2*^*−/−*^ MEFs. **(C)** Representative imaging of autophagic structures that were observed only in differentiated *Agpat2*^−/−^ MEFs. **(D)** Relative percentage of lipid-laden cells containing more than 20 autophagic compartments per whole cell. **(E)** Representative imaging of plasma membrane contrasting the differences in the density of caveolae (red arrowheads) in differentiated MEFs of both genotypes. **(F)** Quantification of plasma membrane-associated caveloae normalized against membrane area. For image analysis and quantification, 10 differentiated lipid-laden cells per independent sample were imaged in each experiment with a total of N = 4 samples per experimental group).](gr6){#fig6}

![**Overexpression of PPARγ2 increases the proportion of lipid laden-cells and the gene expression profile but not the morphology of differentiated *Agpat2***^***−/−***^**MEFs**. **(A)** qPCR quantification of C/EBPs and PPARγ mRNA levels at early and late stages of adipogenic differentiation. Data were normalized to 36B4 mRNA levels and expressed as relative fold changes to non-differentiated *Agpat2*^*+/+*^ MEFs at day 0. **(B)** Immunoblot analysis of whole-cell protein extracts from *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ MEFs at different days of differentiation. 50 μg of proteins were loaded, β-actin was used as loading control. **(C)** Confocal immunofluorescence analysis of PPARγ in *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ MEFs at two different stages of adipocyte differentiation. Graphs show the relative total immunofluorescence signal of nuclear PPARγ per cell. **(D)** Time-line showing the adipogenic differentiation protocol used on primary cultures of *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ MEFs previously infected with recombinant adenoviruses. **(E)** Adipogenic differentiation expressed as percentage of BODIPY stained cell after 6 days of differentiation. **(F)** Total cellular triglycerides quantified by an enzymatic-colorimetric method. **(G)** mRNA levels of adipogenic transcription factors and adipocyte related markers were quantified by qPCR. Gene expression was normalized to 36B4 mRNA levels and presented as fold-change relative to non-differentiated *Agpat2*^*+/+*^ MEFs. **(H)** Three dimensional digital reconstruction of fluorescence stacks of differentiated *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ MEFs immunostained with anti-Perilipin-1 antibody (pink). Neutral lipids were stained with BODIPY (green). All bar graphs show mean ± SD of three independent experiments (N \> 6). \*\*\* (p \< 0.001), \*\*(p \< 0.01) and \*(p \< 0.05) denote significant difference compared to *Agpat2*^+/+^ MEFs.](gr7){#fig7}

![**Phospholipid quantification in differentiated *Agpat2***^**+/+**^**and *Agpat2***^**−/−**^**MEFs**. **(A)** Pathways for PA and phospholipid synthesis in mammals. **(B--C)** Electron spray ionization-mass spectrometric analysis of phospholipids in differentiated *Agpat2*^*+/+*^ and *Agpat2*^*−/−*^ MEFs. AGPAT: 1-acyl-sn-glycerol-3-phosphate acyltransferase; CL: cardiolipin; DAG: diacylglycerol; LPA: lysophosphatidic acid; PA: phosphatidic acid; PC: phosphatidylcholine; PE: phosphatidylethanolamine; PG: phosphatidylglycerol; PI: phosphatidylinositol; PS: phosphatidylserine; TAG: triacylglycerol. All bar graphs show mean ± SD of three independent experiments (N \> 6). \*\*\*p \< 0.001, \*\*p \< 0.01 and \*p \< 0.05 denote significant difference compared to differentiated *Agpat2*^+/+^ MEFs.](gr8){#fig8}
